Current concepts review: Venous thromboembolic disease in foot and ankle surgery

Foot and Ankle International

Volumn 28, Issue 11, 2007, Pages 1207-1216

  Mayle Jr , Robert E ^a   DiGiovanni, Christopher W ^a   Lin, Sheldon S ^a   Tabrizi, Payam ^a   Chou, Loretta B ^a,b  

^a Stanford University ^*

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; REVIPARIN; WARFARIN;

COLOR ULTRASOUND FLOWMETRY; FOOT SURGERY; HUMAN; IMPEDANCE PLETHYSMOGRAPHY; LUNG EMBOLISM; PATHOPHYSIOLOGY; PHLEBOGRAPHY; PHYSICAL EXAMINATION; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; PROTECTIVE CLOTHING; REVIEW; RISK FACTOR; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; VENOUS THROMBOEMBOLISM;

ANKLE; ANTICOAGULANTS; DIAGNOSTIC IMAGING; FOOT; HEMORRHAGE; HUMANS; INTERMITTENT PNEUMATIC COMPRESSION DEVICES; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; RISK FACTORS; STOCKINGS, COMPRESSION; THROMBOCYTOPENIA; VENOUS THROMBOEMBOLISM;

EID: 35649016695     PISSN: 10711007     EISSN: None     Source Type: Journal    
DOI: 10.3113/FAI.2007.1207     Document Type: Review

References (90)

1. Abdollahi, M; Cushman, M; Rosendaal, FR: Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb. Haemost. 89:493-498, 2003.
2. Ageno, W; Piantanida, E; Dentali. F; et al.: Body mass index is associated with the development of the post-thrombotic syndrome. Thromb. Haemost. 89:305-309, 2003.
3. Agu, O; Hamilton, G; Baker, D: Graduated compression stockings in the prevention of venous thromboembolism. Br. J. Surg. 86:992-1004, 1999.
4. Amaragiri, SV; Lees, TA: Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 3:CD001484, 2000.
5. Amstutz, HC; Friscia DA; Dorey, F; Carney, BT: Warfarin prophylaxis to prevent mortality from pulmonary embolism after total hip replacement. J. Bone Joint Surg. 71A:321-326, 1989.
6. Appleby, RD; Olds, RJ: The inherited basis of venous thrombosis. Pathology 29:341-347, 1997.
7. Arepally, G; Cines, DB: Pathogenesis of heparin-induced thrombocytopenia and thrombosis. Autoimmun. Rev. 1:125-132, 2002.
8. Bauer, KA; Eriksson, BI; Lassen, MR; Turpie, AG; et al.: Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N. Eng. J. Med. 345:1305-1310, 2001.
9. Bijsterveld, NR; Moon, AH; Boekhodlt, SM; et al.: Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers. Circulation 106:2550-2554, 2002.
10. Bijsterveld, NR; Vink, R; van Aken, BE; et al.: Recombinant factor VIIa reverses the anticoagulant effect of the long acting pentasaccharide idraparinux in healthy volunteers. Br. J. Haematol. 124:653-658, 2004.
11. Buller, H; Davidson, B; Decousus, H; et al.: Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: A randomized trial. Ann. Intern. Med. 140:867-873, 2004.
12. Caprini, JA: Thrombosis risk assessment as a guide to quality patient care. Dis. Mon. 51:70-78, 2005.
13. Cirlincione, AS; Mendicino, R; Catanzariti, R; Grossman, J: Low-molecular-weight heparin for deep vein thrombosis prophylaxis in foot and ankle surgery: a review. J. Foot Ankle Surg. 40:96-100, 2001.
14. Clagett, GP; Anderson, Jr FA; Geerts, WH; et al.: Prevention of venous thromboembolism. Chest 114:531S-560S, 1998.
15. Colwell, CW: Evidence-based guidelines for venous thromboembolism prophylaxis in orthopedic surgery. Orthopedics 30:129-135, 2007.
16. Colwell, CW, Jr; Spiro, TE: Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty. Clin. Orthop. 319:215-222, 1995.
17. Comerota, AJ; Chouhan, V; Harada, RN; et al.: The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann. Surg. 226:306-314, 1997.
18. Cushman, M: Epidemiology and risk factors for venous thrombosis. Semin. Hematol. 44:62-69, 2007.
19. Dahl, OE; Caprini, JA; Colwell, CW; et al.: Fatal vascular outcomes following major orthopaedic surgery. Thromb. Haemost. 93:860-866, 2005.
20. Delis, KT; Hunt, N; Strachan, RK; Nicolaides, AN: Incidence, natural history, and risk factors of deep vein thrombosis in elective knee arthroscopy. Thromb. Haemost. 86:817-821, 2001.
21. DiGiovanni, CW; Restrepo, A; Gonzalez Della Valle, AG; et al.: The safety and efficacy of intraoperative heparin in total hip arthroplasty. Clin. Orthop. 379:178-185, 2000.
22. DiMinno, G; Mannucci, PM; Tufano, A; et al.: The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism. J. Thromb. Haemost. 3:1459-1466, 2005.
23. Edmonds, MJ; Crichton, TJ; Runciman, WB; Pradhan, M: Evidence-based risk factors for postoperative deep vein thrombosis. ANZ J. Surg. 74:1082-1097, 2004.
24. Eisele, R; Kinzl, L; Koelsch, T: Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombus. J. Bone Joint Surg. 89-A:1050-1056, 2007.
25. Eklöf, B; Maksimovic, D; Caprini, JA; Glase, C: Air travel-related venous thromboembolism. Dis Mon. 51:200-207, 2005.
26. Eriksson, BI; Bauer, KA; Lassen MR; Turpie, ACG : Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip fracture surgery. N. Eng. J. Med. 345:1298-1304, 2001.
27. Fitzgerald, RH; Spiro TE; Trowbridge AA; et al.: Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin. J. Bone Joint Surg. 83-A:900-906, 2001.
28. Freedman, KB; Brookenthal, KR; Fitzgerald, RH; Williams, S; Lonner, JH: A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J. Bone Joint Surg. 82A:929-938, 2000.
29. Geerts, WH; Pineo, GF; Heit, JA; et al.: Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(3 Suppl):338S-400S, 2004.
30. Girolami, B; Girolami, A: Heparin-induced thrombocytopenia: a review. Semin. Thromb. Hemost. 32:803-809, 2006.
31. Goldhaber, SZ: Medical progress: Pulmonary embolism. N. Eng. J. Med. 339:93-104, 1998.
32. Goldhaber, SZ; Tapson, VF; DVT FREE Steering Committee: A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am. J. Cardiol. 93:259-262, 2004.
33. Gonzalez, R; Haines, K; Nelson, LG; Gallagher, SF; Murr, MM: Predictive factors of thromboembolic events in patients undergoing Roux-en-Y gastric bypass. Surg. Obes. Relat. Dis. 2:30-35, 2006.
34. Handoll, HHG; Farrar, MJ; McBirnie, J; et al.: Heparin, low-molecular-weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database Syst Rev 4:CD000305, 2002.
35. Hanslow, SS; Grujic, L; Slater, HK; Chen, D: Thromboembolic disease after foot and ankle surgery. Foot Ankle Int. 27:693-695, 2006.
36. Jorgensen, PS; Warming, T; Hansen, K; et al.: Low-molecular-weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast: a venographic controlled study. Thromb. Res. 105:477-80, 2002.
37. Kakkos, SK; Daskalopoulou, SS; Daskalopoulos, ME; Nicolaides, AN; Geroulakos, G: Review of the value of graduated elastic compression stockings after deep vein thrombosis. Thromb. Haemost. 96:441-445, 2006.
38. Kearon, C: Duration of venous thromboembolism prophylaxis after surgery. Chest 124(6 Suppl):386S-392S, 2003.
39. Kearon, C; Julian, JA; Math, M; Newman, TE; Ginsberg, JS: Noninvasive diagnosis of deep venous thrombosis. Ann. Int. Med. 128:663-667, 1998.
40. Kock, HJ; Schmit-Neuerburg, KP; Hanke, J; Rudofsky, G; Hirche, H: Thrombo-prophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg. Lancet 346:459-461, 1995.
41. Kolbach, DN; Sandbrink, MW; Hamulyak, K; Neumann, HA; Prins, MH: Non-pharmaceutical measures for prevention of post-thrombotic syndrome, Cochrane Database Syst Rev 1:CD004174, 2004.
42. Kucher, N; Tapson, VF; Goldhaber, SZ; DVT FREE Streeting Committee: Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients. Thromb. Haemost. 93:494-498, 2005.
43. Kujath, P; Spannagel, U; Habscheid, W: Incidence and prophylaxis of deep venous thrombosis in outpatients with injuries of the lower limb. Heamostasis 23[Suppl 1]:20-26, 1993.
44. Lapidus, LJ; Rosfors, S; Ponzer, S; et al: Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture: a randomized, placebo-controlled study. J. Orthop. Trauma 21:52-57, 2007.
45. Lassen, RM; Borris, LC; Nakov, RL: Use of low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization. N. Eng. J. Med. 347:726-730, 2002.
46. Lin, PP; Graham, D; Hann, LE; Boland, PJ; Healey, JH: Deep venous thrombosis after orthopedic surgery in adult cancer patients. J. Surg. Oncol. 68:41-47, 1998.
47. Lindhoff-Last, E; Wenning, B; Gerdsen, MS; Bauersachs, R; Wagner, R: Risk factors and long-term follow-up of patients with the immune type of heparin-induced thrombocytopenia. Clin. Appl. Thromb. Hemost. 8:347-352, 2002.
48. Lonner, JH; Frank, J; McGuire, K; Lotke, PA: Postthrombotic syndrome after asymptomatic deep vein thrombosis following total knee and hip arthroplasty. Am. J. Orthop. 35:469-472, 2006.
49. Lotke, PA; Callaghan, JJ; Dorr, LD; Engh, GA; et al.: Prophylaxis for thromboembolic disease. J. Arthroplasty 20:273-274, 2005.
50. Lotke, P; Lonner, J: The benefit of aspirin chemoprophylaxis for thromboembolism after total knee arthroplasty. Clin. Orthop. 452:175-180, 2006.
51. Malone, PC; Agutter, PS: Review: The aetiology of deep venous thrombosis. QJM 99:581-593, 2006.
52. Menajovsky, LB: Heparin-induced thrombocytopenia: clinical manifestations and management strategies. Am. J. Med. 118[Suppl 8A]:21S-30S, 2005.
53. Mizel, MS; Temple, HT; Michelson JD; et al.: Thromboembolism after foot and ankle surgery. Clin. Orthop. 348:180-185, 1998.
54. Montgomery, KD; Potter, HG; Helfet, DL: The detection and management of proximal deep vein thrombosis in patients with acute acetabular fractures: a follow up report. J. Orthop. Trauma 11:330-336; 1997.
55. National Institutes of Health: Prevention of venous thrombosis and pulmonary embolism. NIH Conensus Development. J. Am. Med. Assoc. 256:744-749, 1986.
56. Paiement, GD; Wessinger, SJ; Hughes, R; Harris, WH: Routine use of adjusted low dose warfarin to prevent venous thromboembolism after total hip replacement. J. Bone Joint Surg. 75A:893-898, 1993.
57. Paeiment, GD; Wessinger, SJ; Waltman, AC; Harris, WH: Surveillance of deep vein thrombosis in asymptomatic total hip replacement patients. Am. J. Surg. 155:400-404, 1988.
58. Palareti, G; Cosmi, B; Lignani, C: Diagnosis of deep vein thrombosis. Semin. Thromb. Hemost. 32:659-672, 2006.
59. Piegsa, K; Guillebaud, J: Oral contraceptives and the risk of DVT. Practitioner 240:544-551, 1996.
60. PERSIST investigators: A novel long-acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A Phase II evaluation. J. Thromb. Haemost. 2:47-53, 2004.
61. Pulmonary Embolism Prevention (PEP) Trial:Prevention of pulmonary embolism and deep vein thrombosis with low-dose aspirin. Lancet 355:1295-1302, 2000.
62. Radl, R; Kastner, N; Aiger, C; et al.: Venous thrombosis after hallux valgus surgery. J. Bone Joint Surg. 85-A:1204-1208, 2003.
63. Ramos, J; Perrotta. C; Badariotti, G; Berenstein, G: Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy. Cochrane Database Syst Rev 18:CD005259, April 18, 2007.
64. Raskub, GE; Hull, RD; Pineo, GF: Venous Thrombosis. In Lichtman, MA; Beutler, E; Kipps, TJ; et al. (eds.), Williams Hematology, 7th Edition. McGraw Hill Professional, New York, 2006.
65. Salvati, EA; Gonzalez Della Valle, A; Westrich, GH; et al.: The John Charnley Award. Heritable thrombophilia and development of thromboembolic disease after total hip arthroplasty. Clin. Orthop. 441:40-55, 2005.
66. Salvati, EA; Sharrock, NE; Westrich, G; et al.: Three decades of clinical, basic, and applied research on thromboembolic disease after THA. Clin. Orthop. 459:246-254, 2007.
67. Sculco, TP; Colwell, CW Jr; Pellegrini, VD Jr; Westrich GH; Böttner F: Prophylaxis against venous thromboembolic disease in patients having a total hip or knee arthroplasty. J. Bone Joint Surg. 84A:466-477, 2002.
68. Solis, G; Saxby, T: Incidence of DVT following surgery of the foot and ankle. Foot Ankle Int. 23:411-414, 2002.
69. Spannagel, U; Kujath, P: Low molecular weight heparin for the prevention of thromboembolism in outpatients immobilized by plaster cast. Semin Thromb Hemost. 19[Suppl 1]:131-141, 1993.
70. Syed, FF; Beeching, NJ: Lower-limb deep-vein thrombosis in a general hospital: risk factors, outcomes and the contribution of intravenous drug use. Q.J.M. 98:139-145, 2005.
71. Turpie, A; Bauer, KA; Eriksson, BI; Lassen, MR: Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopaedic surgery using different efficacy end points. Chest 126:501-508, 2004.
72. Turpie, AGG; Bauer, KA; Eriksson, BI; Lassen, MR; PENTATHLON 2000 Study Steering Committee: Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip replacement surgery: a randomized double blind trial. Lancet 359:1721 -1726, 2002.
73. Turpie, AGG; Eriksson, BI; Bauer, KA; Lassen, MR: Advances in therapeutics and diagnostics. Fondaparinux. J. Am. Acad. Orthop. Surg. 12:371-375, 2004.
74. Turpie, AG; Eriksson; BI; Lassen, MR; Bauer, KA: A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery. J. South. Orthop. Assoc. 11:182-188, 2002.
75. United States Department of Health and Human Resources: FDA Public Health Advisory: Reports of epidural or spinal hematomas with the concurrent use of low molecular weight heparin and spinal/epidural anesthesia or spinal puncture. Washington, DC, December 15, 1997.
76. Urbankova, J; Quiroz, R; Kucher, N; Goldhaber, SZ: Intermittent pneumatic compression and deep vein thrombosis prevention. A meta-analysis in post-operative patients. Thromb. Haemost. 94:1181-1185, 2005.
77. Urbano, F: Homan's sign in the diagnosis of deep venous thrombosis. Hospital Physician 37:22-24, 2001.
78. van Weert, H; Dolan, G; Wichers, I; et al.: Spontaneous superficial venous thrombophlebitis: does it increase risk for thromboembolism? A historic follow-up study in primary care. J. Fam. Pract. 55:52-57, 2006.
79. Virchow, R: Cellular Pathology as Based Upon Physiological and Pathological Histology. London: Churchill; 1860
80. Wahlander, K; Larson, G; Lindahl, TL; et al.: Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Thromb. Haemost. 87:580-585, 2002.
81. Warkentin, TE: Think of HIT. Hematology: Am. Soc. Hematol. Educ. Program, 2006:408-414, 2006.
82. Warkentin, TE: Heparin-induced thrombocytopenia: a ten-year retrospective. Ann. Rev. Med. 50:129-147, 1999.
83. Warkentin, TE; Kelton, J: A 14-year study of heparin-induced thromh eytopenia. Am. J. Med. 101:502-507, 1996.
84. Warkentin, TE; Roberts, RS; Hirsch, J; Kelton, JG: An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch. Int. Med. 163:2518-2524, 2003.
85. Wein, L; Wein, S; Haas, SJ; Shaw, J; Krum, H: Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 167:1476-1486, 2007.
86. Weinmann, EE; Salzman, EW: Deep-vein thrombosis. N. Engl. J. Med. 331:1630-1641, 1994.
87. Westrich, GH; Weksler, BB; Glueck, CJ; Blumenthal, BF; Salvati, EA: Correlation of thrombophilia and hypofibrinolysis with pulmonary embolism following total hip arthroplasty: an analysis of genetic factors. J. Bone Joint Surg. 84-A:2161-2167, 2002.
88. Whang, P; Lieberman, J: Low-molecular-weight heparin. J. Am. Acad. Orthop. Surg. 10:299-302, 2002.
89. Wille-Jorgensen, P; Jorgensen, LN; Crawford, M: Asymptomatic post-operative deep vein thrombosis and the development of post-thrombotic syndrome. A systematic review and meta-analysis. Thromb. Haemost. 93:236-241, 2005.
90. Wolf, JM; DiGiovanni, CW: A survey of orthopedics surgeons regarding DVT prophylaxis in foot and ankle trauma surgery. Orthopedics 27:504-508, 2004.